Evidence map›Paper›PMID 36012688›Full record

ArticleInternational journal of molecular sciences2022

Expression of Cell Cycle Markers and Proliferation Factors during Human Eye Embryogenesis and Tumorigenesis.

Josipa Marin Lovrić, Natalija Filipović, Ljubo Znaor, Anita Rančić, Joško Petričević, Nenad Kunac, Violeta Šoljić, Mirna Saraga-Babić, Katarina Vukojević

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Josipa Marin LovrićDepartment of Ophthalmology, University Hospital of Split, 21000 Split, Croatia.
Natalija FilipovićDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, Šoltanska 2, 21000 Split, Croatia.ORCID 0000-0002-8943-4109
Ljubo ZnaorDepartment of Ophthalmology, University Hospital of Split, 21000 Split, Croatia.
Anita RančićDepartment of Ophthalmology, University Hospital of Split, 21000 Split, Croatia.
Joško PetričevićDepartment of Pathology, University of Mostar School of Medicine, 88000 Mostar, Bosnia and Herzegovina.ORCID 0000-0003-1997-852X
Nenad KunacDepartment of Pathology, University Hospital of Split, 21000 Split, Croatia.
Violeta ŠoljićDepartment of Histology and Embryology, University of Mostar School of Medicine, 88000 Mostar, Bosnia and Herzegovina.
Mirna Saraga-BabićDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, Šoltanska 2, 21000 Split, Croatia.
Katarina VukojevićDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, Šoltanska 2, 21000 Split, Croatia.ORCID 0000-0003-2182-2890
University of Split · HRUniversity of Mostar · BA

Funding

Croatian Science Foundation IP-06-2016-2575
6 · The paper itself

Abstract

The expression pattern of the markers p19, Ki-67, MSX1, MSX2, PDL1, pRB, and CYCLINA2 was quantitatively and semiquantitatively analyzed in histologic sections of the developing and postnatal human eye at week 8, in retinoblastoma, and in various uveal melanomas post hoc studies by double immunofluorescence. The p19 immunoreactivity characterized retinal and/or choroidal cells in healthy and tumor tissues: expression was lower in the postnatal retina than in the developing retina and retinoblastoma, whereas it was high in epithelioid melanomas. Ki67 expression was high in the developing eye, retinoblastoma, and choroidal melanomas. MSX1 and MSX2 expression was similar in the developing eye and retinoblastoma, whereas it was absent in the postnatal eye. Their different expression was evident between epithelioid and myxoid melanomas. Similarly, PDL1 was absent in epithelioid melanomas, whereas it was highly expressed in developing and tumor tissues. Expression of pRB and CYCA2 was characteristic of developing and tumorous eye samples but not of the healthy postnatal eye. The observed expression differences of the analyzed markers correlate with the origin and stage of cell differentiation of the tissue samples. The fine balance of expression could play a role in both human eye development and ocular tumorigenesis. Therefore, understanding their relationship and interplay could open new avenues for potential therapeutic interventions and a better understanding of the mechanisms underlying the developmental plasticity of the eye and the development of neoplasms.

Indexed as

MelanomaRetinal NeoplasmsRetinoblastomaCarcinogenesisCell CycleCell ProliferationCell Transformation, NeoplasticEmbryonic DevelopmentHumansInfant, NewbornUveal MelanomaUveal Neoplasmschoroid melanomaCYCLA2eye developmentKi67MSX1MSX2p19PDL-1pRBretinoblastoma

Identifiers

PMID36012688
PMCPMC9409163
OpenAlexW4293030565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.